Drug interactions for the following drug(s)
Applies to: fluticasone propionate 0.05 MG/ACTUAT Dry Powder Inhaler, 60 ACTUAT <> fluticasone propionate 0.05 MG/ACTUAT Dry Powder Inhaler, 60 ACTUAT
The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Fluticasone.
Applies to: gabapentin 600 MG Oral Tablet <> fluticasone propionate 0.05 MG/ACTUAT Dry Powder Inhaler, 60 ACTUAT
The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Gabapentin.
Applies to: gabapentin 600 MG Oral Tablet <> gabapentin 600 MG Oral Tablet
The risk or severity of adverse effects can be increased when Gabapentin is combined with Gabapentin enacarbil.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Applies to: fluticasone propionate 0.05 MG/ACTUAT Dry Powder Inhaler, 60 ACTUAT <> fluticasone propionate 0.05 MG/ACTUAT Dry Powder Inhaler, 60 ACTUAT
Drug1 (rxcui = 896018, name = 60 ACTUAT fluticasone propionate 0.05 MG/ACTUAT Dry Powder Inhaler, tty = SCD). Drug2 (rxcui = 896018, name = 60 ACTUAT fluticasone propionate 0.05 MG/ACTUAT Dry Powder Inhaler, tty = SCD). Drug1 is resolved to fluticasone, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Fluticasone and Fluticasone furoate. Drug1 is resolved to fluticasone furoate, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Fluticasone furoate and Fluticasone. Drug1 is resolved to fluticasone, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Fluticasone and Fluticasone propionate. Drug1 is resolved to fluticasone propionate, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Fluticasone propionate and Fluticasone. Drug1 is resolved to fluticasone propionate, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Fluticasone propionate and Fluticasone furoate. Drug1 is resolved to fluticasone furoate, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Fluticasone furoate and Fluticasone propionate.
Applies to: gabapentin 600 MG Oral Tablet <> fluticasone propionate 0.05 MG/ACTUAT Dry Powder Inhaler, 60 ACTUAT
Drug1 (rxcui = 310433, name = gabapentin 600 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 896018, name = 60 ACTUAT fluticasone propionate 0.05 MG/ACTUAT Dry Powder Inhaler, tty = SCD). Drug1 is resolved to gabapentin, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Gabapentin and Fluticasone propionate. Drug1 is resolved to fluticasone propionate, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Fluticasone propionate and Gabapentin enacarbil.
Applies to: gabapentin 600 MG Oral Tablet <> gabapentin 600 MG Oral Tablet
Drug1 (rxcui = 310433, name = gabapentin 600 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 310433, name = gabapentin 600 MG Oral Tablet, tty = SCD). Drug1 is resolved to gabapentin, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Gabapentin and Gabapentin enacarbil. Drug1 is resolved to gabapentin enacarbil, Drug2 is resolved to gabapentin and interaction asserted in DrugBank between Gabapentin enacarbil and Gabapentin.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.